{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:32:04Z","timestamp":1760059924015,"version":"build-2065373602"},"reference-count":34,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"F. Hoffman-La Roche Ltd.","award":["71095"],"award-info":[{"award-number":["71095"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Alpha-Synuclein (\u03b1-Syn) is a presynaptic neuronal protein implicated in the pathogenesis of Parkinson\u2019s disease (PD) and other synucleinopathies, primarily through its aggregation into insoluble fibrils. The extended \u03b1-Syn half-life necessitates treatment durations that are incompatible with efficient high-throughput drug screening, can risk compound stability or cause cellular toxicity. To address this, we inserted a PEST sequence, a motif known to promote rapid protein degradation, at the C-terminus of the SNCA gene using CRISPR\/Cas9 to create a novel cell line with reduced \u03b1-Syn half-life. This modification accelerates \u03b1-Syn turnover, providing a robust model for studying \u03b1-Syn dynamics and offering a platform that is applicable to other long-lived proteins. Our results demonstrate a six-fold reduction in \u03b1-Syn half-life, enabling the rapid detection of changes in protein levels and facilitating the identification of molecules that modulate \u03b1-Syn production and degradation pathways. Using inhibitors of the proteasome, transcription, and translation further validated the model\u2019s utility in examining various mechanisms that impact protein levels. This novel cell line represents a significant advancement for studying \u03b1-Syn dynamics and offers promising avenues to develop therapeutics for \u03b1-synucleinopathies. Future research should focus on validating this model in diverse experimental settings and exploring its potential in high-throughput screening applications.<\/jats:p>","DOI":"10.3390\/ijms26157205","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T12:56:43Z","timestamp":1753448203000},"page":"7205","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and Characterization of a Novel \u03b1-Synuclein-PEST H4 Cell Line for Enhanced Drug Screening in \u03b1-Synucleinopathies"],"prefix":"10.3390","volume":"26","author":[{"given":"Nancy","family":"Carullo","sequence":"first","affiliation":[{"name":"Therapeutic Modalities, Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., 4058 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktor","family":"Haellman","sequence":"additional","affiliation":[{"name":"Therapeutic Modalities, Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., 4058 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8014-0801","authenticated-orcid":false,"given":"Simon","family":"Gutbier","sequence":"additional","affiliation":[{"name":"Therapeutic Modalities, Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., 4058 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Schlicht","sequence":"additional","affiliation":[{"name":"Therapeutic Modalities, Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., 4058 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thien Thuong","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Therapeutic Modalities, Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., 4058 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Blum Marti","sequence":"additional","affiliation":[{"name":"Therapeutic Modalities, Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., 4058 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Hartz","sequence":"additional","affiliation":[{"name":"Therapeutic Modalities, Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., 4058 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2595-9931","authenticated-orcid":false,"given":"Lothar","family":"Lindemann","sequence":"additional","affiliation":[{"name":"Neuroscience and Rare Diseases, Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Schukur","sequence":"additional","affiliation":[{"name":"Therapeutic Modalities, Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., 4058 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-5793(94)00395-5","article-title":"Identification of Two Distinct Synucleins from Human Brain","volume":"345","author":"Jakes","year":"1994","journal-title":"FEBS Lett."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","article-title":"The Precursor Protein of Non-A\u03b2 Component of Alzheimer\u2019s Disease Amyloid Is a Presynaptic Protein of the Central Nervous System","volume":"14","author":"Iwai","year":"1995","journal-title":"Neuron"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","article-title":"Synuclein: A Neuron-Specific Protein Localized to the Nucleus and Presynaptic Nerve Terminal","volume":"8","author":"Maroteaux","year":"1988","journal-title":"J. Neurosci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"\u03b1-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro","volume":"329","author":"Sharma","year":"2010","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","article-title":"Mice Lacking \u03b1-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System","volume":"25","author":"Abeliovich","year":"2000","journal-title":"Neuron"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Li, D., Liu, K., Li, D., Brunger, A., Li, C., Burr\u00e9, J., and Diao, J. (2025). \u03b1-Synuclein Condensation in Synaptic Vesicle Function and Synucleinopathies. Trends Cell Biol.","DOI":"10.1016\/j.tcb.2025.03.007"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Luo, Y., Qiao, L., Li, M., Wen, X., Zhang, W., and Li, X. (2025). Global, Regional, National Epidemiology and Trends of Parkinson\u2019s Disease from 1990 to 2021: Findings from the Global Burden of Disease Study 2021. Front. Aging Neurosci., 16.","DOI":"10.3389\/fnagi.2024.1498756"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The Epidemiology of Parkinson\u2019s Disease","volume":"403","author":"Darweesh","year":"2024","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the \u03b1-Synuclein Gene Identified in Families with Parkinson\u2019s Disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy Bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"a024091","DOI":"10.1101\/cshperspect.a024091","article-title":"Cell Biology and Pathophysiology of \u03b1-Synuclein","volume":"8","author":"Sharma","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.slasd.2022.05.001","article-title":"A Novel High-Throughput Screening Strategy for Targeting Alpha-Synuclein and Other Long-Lived Proteins","volume":"27","author":"Casalino","year":"2022","journal-title":"SLAS Discov."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-60327-258-2_1","article-title":"Design and Implementation of High-Throughput Screening Assays","volume":"565","author":"Hertzberg","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF01076559","article-title":"PEST Sequences in Calmodulin-Binding Proteins","volume":"149\u2013150","author":"Barnes","year":"1995","journal-title":"Mol. Cell. Biochem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0065-2571(88)90014-3","article-title":"Regulation of Enzyme Levels by Proteolysis: The Role of Pest Regions","volume":"27","author":"Rechsteiner","year":"1988","journal-title":"Adv. Enzym. Regul."},{"key":"ref_16","first-page":"433","article-title":"PEST Sequences Are Signals for Rapid Intracellular Proteolysis","volume":"1","author":"Rechsteiner","year":"1990","journal-title":"Semin. Cell Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nrm2067","article-title":"Functional and Quantitative Proteomics Using SILAC","volume":"7","author":"Mann","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0006-291X(67)90273-2","article-title":"Cycloheximide Resistance in Yeast: A Property of the 60s Ribosomal Subunit","volume":"29","author":"Rao","year":"1967","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_19","unstructured":"Gottlieb, D., and Shaw, P.D. (2013). Antibiotics: Volume I Mechanism of Action, Springer."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1038\/emm.2014.117","article-title":"Degradation of Misfolded Proteins in Neurodegenerative Diseases: Therapeutic Targets and Strategies","volume":"47","author":"Ciechanover","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.tibs.2016.06.004","article-title":"Old Proteins in Man: A Field in Its Infancy","volume":"41","author":"Truscott","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrm3496","article-title":"Protein Homeostasis: Live Long, Won\u2019t Prosper","volume":"14","author":"Toyama","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1517\/14728222.2015.1009448","article-title":"Targeting \u03b1-Synuclein Oligomers by Protein-Fragment Complementation for Drug Discovery in Synucleinopathies","volume":"19","author":"Moussaud","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Fatti, E., Khawaja, S., and Weis, K. (2025). The Dark Side of Fluorescent Protein Tagging\u2014The Impact of Protein Tags on Biomolecular Condensation. Mol. Biol. Cell, 36.","DOI":"10.1091\/mbc.E24-11-0521"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1600-0854.2012.01336.x","article-title":"Assessing the Tendency of Fluorescent Proteins to Oligomerize Under Physiologic Conditions","volume":"13","author":"Costantini","year":"2012","journal-title":"Traffic"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/abio.2001.5562","article-title":"\u03b2-Naphthoflavone, an Inducer of Xenobiotic Metabolizing Enzymes, Inhibits Firefly Luciferase Activity","volume":"304","author":"Wang","year":"2002","journal-title":"Anal. Biochem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jphotobiol.2010.06.015","article-title":"Firefly Luciferase Inhibition","volume":"101","year":"2010","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1038\/s41467-024-50399-6","article-title":"High-Throughput Sensitive Screening of Small Molecule Modulators of Microexon Alternative Splicing Using Dual Nano and Firefly Luciferase Reporters","volume":"15","author":"Best","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_29","unstructured":"Simeonov, A., and Davis, M.I. (2004). Interference with Fluorescence and Absorbance, Eli Lilly & Company and the National Center for Advancing Translational Sciences."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Masato, A., and Bubacco, L. (2024). The ASynuclein Half-Life Conundrum. Neurobiol. Dis., 196.","DOI":"10.1016\/j.nbd.2024.106524"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/pmic.201300553","article-title":"Suspension Trapping (STrap) Sample Preparation Method for Bottom-up Proteomics Analysis","volume":"14","author":"Zougman","year":"2014","journal-title":"Proteomics"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1074\/mcp.TIR119.001385","article-title":"TMT Labeling for the Masses: A Robust and Cost-Efficient, In-Solution Labeling Approach* [S]","volume":"18","author":"Zecha","year":"2019","journal-title":"Mol. Cell. Proteom."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41467-019-13973-x","article-title":"Robust, Reproducible and Quantitative Analysis of Thousands of Proteomes by Micro-Flow LC\u2013MS\/MS","volume":"11","author":"Bian","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_34","unstructured":"Field, A.P. (2024). Discovering Statistics Using IBM SPSS Statistics, SAGE Publications."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7205\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:16:06Z","timestamp":1760033766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":34,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26157205"],"URL":"https:\/\/doi.org\/10.3390\/ijms26157205","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2025,7,25]]}}}